AbstractN-acetyltransferase 2 (NAT2) catalyzes the acetylation of isoniazid to N-acetylisoniazid. NAT2 polymorphism explains 88% of isoniazid clearance variability in adults. We examined the effects of clinical and genetic factors on Michaelis-Menten reaction kinetic constants of maximum velocity (Vmax) and affinity (Km) in children 0–10years old. We measured the rates of isoniazid elimination and N-acetylisoniazid production in the blood of 30 children. Since maturation effects could be non-linear, we utilized a pharmacometric approach and the artificial intelligence method, multivariate adaptive regression splines (MARS), to identify factors predicting NAT2 Vmax and Km by examining clinical, genetic, and laboratory factors in toto. Isonia...
BACKGROUND:Distribution of N-acetyltransferase2 (NAT2) polymorphisms varies considerably among diffe...
Age-related changes in the expression of xenobiotic biotransfor-mation enzymes can result in differe...
N-Acetyltransferase (NAT) N-acetylates various arylamine drugs (e.g., p-aminosalicylate, p-aminobenz...
N-acetyltransferase 2 (NAT2) catalyzes the acetylation of isoniazid to N-acetylisoniazid. NAT2 polym...
Background: Genetic variants in NAT2 are associated with pharmacokinetic variation of isoniazid, the...
Aims: To define the pharmacokinetics of isoniazid (INH) in children with tuberculosis in relation to...
BackgroundIsoniazid (INH) metabolism depends on the N-acetyl transferase 2 (NAT2) enzyme, whose matu...
Isoniazid (INH), a key agent in the treatment of tuberculosis (TB), is metabolized primarily by the ...
UnrestrictedPediatric tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection results ...
Isoniazid (INH), recommended by WHO (World Health Organization) in the treatment of tuberculosis (TB...
Isoniazid is a therapeutic agent for the treatment of latent tuberculosis infection. Genetic variant...
N-acetyltransferase 2 (NAT2) is the main enzyme metabolizing isoniazid and genotype-based treatment ...
Arylamine N-acetyltransferases (NATs) catalyse the N-acetylation of arylamines, arylhydroxylamines a...
Arylamine N-acetyltransferase (NAT) was first identified as the inactivator of the anti-tubercular d...
Arylamine N-acetyltransferases (NATs) catalyse the N-acetylation of arylamines, arylhydroxylamines a...
BACKGROUND:Distribution of N-acetyltransferase2 (NAT2) polymorphisms varies considerably among diffe...
Age-related changes in the expression of xenobiotic biotransfor-mation enzymes can result in differe...
N-Acetyltransferase (NAT) N-acetylates various arylamine drugs (e.g., p-aminosalicylate, p-aminobenz...
N-acetyltransferase 2 (NAT2) catalyzes the acetylation of isoniazid to N-acetylisoniazid. NAT2 polym...
Background: Genetic variants in NAT2 are associated with pharmacokinetic variation of isoniazid, the...
Aims: To define the pharmacokinetics of isoniazid (INH) in children with tuberculosis in relation to...
BackgroundIsoniazid (INH) metabolism depends on the N-acetyl transferase 2 (NAT2) enzyme, whose matu...
Isoniazid (INH), a key agent in the treatment of tuberculosis (TB), is metabolized primarily by the ...
UnrestrictedPediatric tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection results ...
Isoniazid (INH), recommended by WHO (World Health Organization) in the treatment of tuberculosis (TB...
Isoniazid is a therapeutic agent for the treatment of latent tuberculosis infection. Genetic variant...
N-acetyltransferase 2 (NAT2) is the main enzyme metabolizing isoniazid and genotype-based treatment ...
Arylamine N-acetyltransferases (NATs) catalyse the N-acetylation of arylamines, arylhydroxylamines a...
Arylamine N-acetyltransferase (NAT) was first identified as the inactivator of the anti-tubercular d...
Arylamine N-acetyltransferases (NATs) catalyse the N-acetylation of arylamines, arylhydroxylamines a...
BACKGROUND:Distribution of N-acetyltransferase2 (NAT2) polymorphisms varies considerably among diffe...
Age-related changes in the expression of xenobiotic biotransfor-mation enzymes can result in differe...
N-Acetyltransferase (NAT) N-acetylates various arylamine drugs (e.g., p-aminosalicylate, p-aminobenz...